El director general de la Organización Mundial de la Salud, Tedros Adhanom, ha anunciado que su organización va a retomar los ensayos clínicos con la hidroxicloroquina para tratar la COVID-19. Esto...
Read moreStaidson, a biopharmaceutical company developing investigational products by targeting the complement system and Pivotal, a European-wide full-service CRO, headquartered in Madrid, have announced t...
Read moreVTX-803, co-desarrollado por el Cima Universidad de Navarra y Vivet Therapeutics, está indicado para el tratamiento de la colestasis intrahepática familiar progresiva de tipo 3
Read moreThe COVID-19 fund of the Carlos III Health Institute (ISCIII) awards a project to the Barcelona Supercomputing Center (BSC), lead by Víctor Guallar, in collaboration of Nostrum Biodiscovery ...
Read moreThe biotech company Oxolife, created to develop a new treatment to improve the female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Ass...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read moreFarmaindustria expone en la cumbre empresarial ‘Empresas españolas liderando el futuro’, de CEOE, una batería de posibles soluciones que ofrece el sector para hacer frente a la crisis originada ...
Read moreLos laboratorios adheridos al Código de Buenas Prácticas de Farmaindustria publican, por quinto año, las colaboraciones con los agentes del sector
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has presented t...
Read moreUn paso adelante en la optimización de fármacos para la inmunoterapia del cáncer es el nuevo logro del grupo del CiQUS de la USC que dirige el profesor Eddy Sotelo. En colaboración con la Universi...
Read moreOrigo Biopharma has announced the closing of a €2,3 million Series Seed financing, with the participation from Sabadell Asabys, XesGalicia and the founding shareholders. The financing, led ...
Read more